Compare KZR & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KZR | LFVN |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 51.5M |
| IPO Year | 2018 | 1996 |
| Metric | KZR | LFVN |
|---|---|---|
| Price | $7.36 | $4.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.00 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 88.4K | 77.7K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | 33.33 | ★ 226.09 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $203,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.95 |
| Revenue Growth | N/A | ★ 1.86 |
| 52 Week Low | $3.53 | $3.90 |
| 52 Week High | $7.55 | $15.00 |
| Indicator | KZR | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 62.35 | 37.94 |
| Support Level | $6.06 | $3.99 |
| Resistance Level | N/A | $5.37 |
| Average True Range (ATR) | 0.18 | 0.21 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 89.12 | 41.67 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.